Nrf2在帕金森病治疗中的新兴作用:一个关键的重新评估
Veerta Sharma1, Prateek Sharma1, Thakur Gurjeet Singh2
1Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India.
Metabolic brain disease
|December 19, 2024
概括
核因子红色素2相关因子2 (Nrf2) 在治疗帕金森病 (PD) 中表现有前途. 激活Nrf2可能提供新的疗法,通过减少氧化应激和炎症来对抗PD的运动和非运动症状.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元的退化,导致运动和非运动症状.
- 氧化应激,神经炎症和线粒体功能障碍是PD病变发生的关键因素.
- 目前的PD疗法主要管理运动症状,因此需要针对疾病调节和非运动缺陷的新疗法.
研究的目的:
- 审查核素红色素2相关因子2 (Nrf2) 的结构和功能.
- 探索调节Nrf2活动的分子信号通路.
- 突出Nrf2激活剂作为帕金森病的潜在治疗剂.
主要方法:
- 文献综述侧重于Nrf2通路和帕金森病.
- 分析分子信号通路,包括GSK-3β,PI3K,AMPK,MAPK,NF-κB和P62.
- 检查Nrf2在抵消氧化应激,神经炎症和线粒体功能障碍方面的作用.
主要成果:
- Nrf2调节抗氧化和细胞保护基因,抵消PD相关的病理.
- 不同的信号通路 (GSK-3β,PI3K,AMPK,MAPK,NF-κB,P62) 影响了Nrf2的活动.
- Nrf2激活显示了改善PD病理和症状的潜力.
结论:
- Nrf2是一种关键的转录因子,具有与帕金森病相关的神经保护能力.
- 准Nrf2通路为PD提供了一个有前途的治疗策略.
- Nrf2激活剂代表了帕金森病治疗的潜在疾病修饰剂.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.4K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
相关概念视频
01:24Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
01:15Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K